{"componentChunkName":"component---src-pages-oyw-jsx","path":"/pt/oyw/","result":{"data":{"allFile":{"edges":[{"node":{"name":"annelisse","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/d581c5192d2631dae5e891e3743543aa/89f4f/annelisse.jpg","srcSet":"/static/d581c5192d2631dae5e891e3743543aa/f836f/annelisse.jpg 200w,\n/static/d581c5192d2631dae5e891e3743543aa/89f4f/annelisse.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"ambassador","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":0.823045267489712,"src":"/static/5bc9ced0be1a0389a8f1dfa64502d84b/bbbeb/ambassador.png","srcSet":"/static/5bc9ced0be1a0389a8f1dfa64502d84b/69585/ambassador.png 200w,\n/static/5bc9ced0be1a0389a8f1dfa64502d84b/497c6/ambassador.png 400w,\n/static/5bc9ced0be1a0389a8f1dfa64502d84b/bbbeb/ambassador.png 534w","sizes":"(max-width: 534px) 100vw, 534px"}}}},{"node":{"name":"diverse","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1.238938053097345,"src":"/static/64760b299f9730082461c955027ce1ba/b3779/diverse.png","srcSet":"/static/64760b299f9730082461c955027ce1ba/b3779/diverse.png 140w","sizes":"(max-width: 140px) 100vw, 140px"}}}},{"node":{"name":"globe","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":0.5507246376811594,"src":"/static/6a92e98ff442643038b3f48253630b25/ea08a/globe.png","srcSet":"/static/6a92e98ff442643038b3f48253630b25/ea08a/globe.png 76w","sizes":"(max-width: 76px) 100vw, 76px"}}}},{"node":{"name":"gonzalo","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/c80bdc90ccde2216f27b63eb9759cba6/89f4f/gonzalo.jpg","srcSet":"/static/c80bdc90ccde2216f27b63eb9759cba6/f836f/gonzalo.jpg 200w,\n/static/c80bdc90ccde2216f27b63eb9759cba6/89f4f/gonzalo.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"jason","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/4fe97347d233123264c8bc1e6b714cb8/89f4f/jason.jpg","srcSet":"/static/4fe97347d233123264c8bc1e6b714cb8/f836f/jason.jpg 200w,\n/static/4fe97347d233123264c8bc1e6b714cb8/89f4f/jason.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"katherine","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/cb243558c9d97b52be801c44dc662186/f836f/katherine.jpg","srcSet":"/static/cb243558c9d97b52be801c44dc662186/f836f/katherine.jpg 200w","sizes":"(max-width: 200px) 100vw, 200px"}}}},{"node":{"name":"marcos","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/9cff9f0ceae27d0fff42f176c968a628/89f4f/marcos.jpg","srcSet":"/static/9cff9f0ceae27d0fff42f176c968a628/f836f/marcos.jpg 200w,\n/static/9cff9f0ceae27d0fff42f176c968a628/89f4f/marcos.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"nathan","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/b928010678614452e2bfe479ec54ae48/2244e/nathan.jpg","srcSet":"/static/b928010678614452e2bfe479ec54ae48/f836f/nathan.jpg 200w,\n/static/b928010678614452e2bfe479ec54ae48/2244e/nathan.jpg 400w","sizes":"(max-width: 400px) 100vw, 400px"}}}},{"node":{"name":"oyw","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1.2658227848101267,"src":"/static/f602d82cc348a063a685b1a77cfa1916/ac08b/oyw.png","srcSet":"/static/f602d82cc348a063a685b1a77cfa1916/69585/oyw.png 200w,\n/static/f602d82cc348a063a685b1a77cfa1916/497c6/oyw.png 400w,\n/static/f602d82cc348a063a685b1a77cfa1916/ac08b/oyw.png 724w","sizes":"(max-width: 724px) 100vw, 724px"}}}},{"node":{"name":"semicolon","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1.1323529411764706,"src":"/static/738f61f80849127d9c9cdc250c1a0dbc/52840/semicolon.png","srcSet":"/static/738f61f80849127d9c9cdc250c1a0dbc/52840/semicolon.png 77w","sizes":"(max-width: 77px) 100vw, 77px"}}}},{"node":{"name":"veronica","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/4ff982b6354ec2c6c234bfee338664b3/07ab6/veronica.jpg","srcSet":"/static/4ff982b6354ec2c6c234bfee338664b3/f836f/veronica.jpg 200w,\n/static/4ff982b6354ec2c6c234bfee338664b3/07ab6/veronica.jpg 225w","sizes":"(max-width: 225px) 100vw, 225px"}}}},{"node":{"name":"sebastian","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/608a05b8cda6a4e1919ac2ca8054cc7a/89f4f/sebastian.jpg","srcSet":"/static/608a05b8cda6a4e1919ac2ca8054cc7a/f836f/sebastian.jpg 200w,\n/static/608a05b8cda6a4e1919ac2ca8054cc7a/89f4f/sebastian.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"youth","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1.0963855421686748,"src":"/static/032b4e8384d0b9b398b26d747f8b10e4/3df8b/youth.png","srcSet":"/static/032b4e8384d0b9b398b26d747f8b10e4/3df8b/youth.png 182w","sizes":"(max-width: 182px) 100vw, 182px"}}}},{"node":{"name":"yulie","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/005ca4c8b3ede9628d6e4123174079e5/f836f/yulie.jpg","srcSet":"/static/005ca4c8b3ede9628d6e4123174079e5/f836f/yulie.jpg 200w","sizes":"(max-width: 200px) 100vw, 200px"}}}},{"node":{"name":"amil","childImageSharp":{"fluid":{"base64":"data:image/png;base64,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","aspectRatio":1,"src":"/static/6a45b7f532364a196197e96f5b105fe9/a5370/amil.png","srcSet":"/static/6a45b7f532364a196197e96f5b105fe9/69585/amil.png 200w,\n/static/6a45b7f532364a196197e96f5b105fe9/a5370/amil.png 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}},{"node":{"name":"madhav","childImageSharp":{"fluid":{"base64":"data:image/jpeg;base64,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","aspectRatio":1,"src":"/static/7c177ee0ab6b3f978bc9e3716150a765/89f4f/madhav.jpg","srcSet":"/static/7c177ee0ab6b3f978bc9e3716150a765/f836f/madhav.jpg 200w,\n/static/7c177ee0ab6b3f978bc9e3716150a765/89f4f/madhav.jpg 350w","sizes":"(max-width: 350px) 100vw, 350px"}}}}]}},"pageContext":{"language":"pt","intl":{"language":"pt","languages":["en","es","pt"],"messages":{"404.header":"Oops!","404.error":"Parece que não conseguimos encontrar a página que procura.","404.code":"Código de erro: 404","404.back":"Voltar à página inicial","dashboard.header":"Dashboard de Nuestros Datos Recolectados","dashboard.sub-header":"Tu tos nos ayuda a mejorar nuestro modelo predictivo, siendo <b>crucial</b> en la lucha contra <b>COVID-19</b>. ¡Mirá el progreso que hemos logrado y doná tu tos!","dashboard.button":"Contribua com sua tosse","dashboard.donatedCoughs":"Tosses Doadas","footer.cookiePolicy":"Política de Cookies","footer.cookieSettings":"Definições de cookies","footer.privacyPolicy":"Política de Privacidade","footer.dontSellPersonalInfo":"Não venda minhas informações pessoais","footer.copyrightInformation":"©2021 Virufy  |  Virufy. Direitos Reservados.   |  Todos os direitos reservados.","footer.nonprofit":"Com base nesta pesquisa passada, Virufy está a desenvolver um algoritmo de IA que pode ser usado para prever com precisão uma infecção por COVID-19 em minutos, com base em gravações de sons de tosse. No entanto, ao contrário das pesquisas anteriores sobre tosse COVID-19 que visavam a população dos EUA, a Virufy pretende recolher dados de múltiplos locais em todo o mundo. Sendo uma iniciativa gerida por voluntários que abrange cinco continentes, a Virufy está a desenvolver um modelo de detecção da COVID-19 com maior inclusão racial e espacial através de dados que incluem uma gama de etnias e diferenças fonológicas específicas da comunidade.","footer.email":"info@virufy.org","footer.address":"4546 El Camino Real B10 #614, Los Altos, California 94022, USA","getInvolved.availableRoles.join":"Junte-se à equipe Virufighter","getInvolved.availableRoles.fontHeading":"Virufy é inteiramente dirigida por voluntários e empresas associadas pro bono. Junte-se à nossa equipe de ritmo acelerado e orientada para a missão para colocar suas habilidades em prática para frear a propagação da pandemia globalmente.","getInvolved.availableRoles.fontheadingBold":"Tem o que é necessário? Confira as oportunidades abaixo!","getInvolved.availableRoles.jobOpenings":"Vagas de trabalho abertas","getInvolved.availableRoles.applyNow":"Aplicar agora","getInvolved.availableRoles.location":"Localização","getInvolved.topFold.joinTitle":"Junte-se à luta para deter a COVID-19","getInvolved.topFold.details":"Acolhemos pessoas apaixonadas de todas as origens e experiências para nos ajudar a acabar com a COVID-19. Quando você for um humanitário, especialista ou simplesmente ansioso para causar impacto, há uma infinidade de maneiras de se envolver com a missão da Virufy.","getInvolved.donate.title":"Fazer uma doação","getInvolved.donate.details":"Doe agora para ajudar a Virufy a realizar seu trabalho vital de trazer a todos a detecção rápida e gratuita de doenças","getInvolved.donate.donateButton":"Doe para apoiar nossa organização","getInvolved.shareCough.title":"Compartilhe sua tosse","getInvolved.shareCough.details":"Doar sua tosse em nosso estudo ajuda a refinar a capacidade preditiva de nossa IA de reconhecer a COVID-19.","getInvolved.shareCough.getTheApp":"CONTRIBUA COM SUA TOSSE","getInvolved.nextSteps.contribute.title":"Parceiro conosco","getInvolved.nextSteps.contribute.details":"Trabalhamos com médicos, tecnologia, governo e outras organizações estabelecidas em todo o mundo para moldar e cumprir a missão da Virufy.","getInvolved.nextSteps.contribute.learnmore":"Quer aprender mais?","getInvolved.nextSteps.contribute.faq":"Veja nossa página de Perguntas Mais Frequentes","getInvolved.nextSteps.contribute.question":"Querendo ser parceiro?","getInvolved.nextSteps.contribute.linkText":"Conectar-se a nós","getInvolved.nextSteps.join.title":"Junte-se à equipe Virufighter","getInvolved.nextSteps.join.details":"Somos uma equipe de ritmo rápido e orientada para a missão, combinando nossas habilidades únicas para conter a propagação da pandemia globalmente. Nossos voluntários abrangem mais de 25 países, e nosso trabalho tem potencial para impactar milhões de vidas.","getInvolved.nextSteps.join.question":"Entusiasmados para ajudar?","getInvolved.nextSteps.join.linkText":"Veja nossos roles disponíveis","index.section1.header":"Transformando a saúde global um clique de cada vez","index.section1.pg":"Virufy é uma organização sem fins lucrativos que está desenvolvendo uma tecnologia de inteligência artificial (IA) para <span class=\"font-bold\">detectar COVID-19</span> a partir de padrões de tosse, de forma <span className=\"font-bold\">rápida</span> e sem custos por meio do uso de um smartphone.","index.section1.coughLink":"CONTRIBUA COM SUA TOSSE","index.section1.donateLink":"DOE","index.section2.header":"Nosso impacto global","index.section2.pg1":"Virufy tem como objetivo mudar a forma como os cuidados com a saúde são experimentados, capacitando as pessoas em todo o mundo com a detecção rápida e gratuita de doenças. Não importa onde você esteja no mundo, tudo o que você precisa é de um dispositivo móvel e do aplicativo Virufy.","index.section2.pg2":"Não importa onde você esteja no mundo, tudo o que você precisa é de um dispositivo móvel e do aplicativo Virufy.","index.section2.learnMoreLink":"APRENDA MAIS","index.section3.howItWorks":"COMO FUNCIONA","index.section3.header":"Nossa visão","index.section3.sub-header":"Estamos coletando tosse para refinar o nosso algoritmo de IA, e implementaremos um processo de detecção em três etapas que ajudará a contribuir para um diagnóstico COVID-19 rápido e fácil em benefício de países de todo o mundo, especialmente países de baixa renda.<br>Ajude a apoiar a nossa visão doando hoje uma tosse.","index.section3.header1":"Você grava a sua tosse","index.section3.header2":"A IA analisa a assinatura respiratória","index.section3.header3":"A assinatura de COVID-19 é detectada","index.section3.tryItOutLink":"EXPERIMENTE","index.section4.header":"Nossa história","index.section4.pg1":"Em março de 2020, fomos pioneiros em um aplicativo móvel com tecnologia de IA para detectar COVID-19.","index.section4.pg2":"Agora, Virufighters de cinco continentes estão empenhados em tornar a detecção de doenças instantânea e gratuita por meio da inovação tecnológica","index.section4.knowUsLink":"CONHEÇA O VIRUFY","index.section4.header2":"Somos apoiados por","index.faq.distinguishableQ":"Por que as tosses COVID-19 são distinguíveis?","index.faq.distinguishableA":"Semelhante a outras doenças respiratórias, a COVID-19 cria uma assinatura respiratória única na garganta e nos pulmões que é distinta de outras infecções respiratórias que produzem uma tosse úmida. Consequentemente, foi sugerido que os sons da tosse podem ser analisados para detectar a COVID-19. Globalmente, esta idéia está sendo ativamente pesquisada por várias instituições de prestígio, incluindo CMU[8], MIT, e Cambridge. Por exemplo, uma pesquisa feita pela Universidade de Cambridge mostrou que um simples classificador de aprendizagem de máquinas binárias é capaz de classificar os pacientes positivos do COVID-19 através da respiração e sons de tosse com alta precisão (AUC = 0,7)[7]. Da mesma forma, pesquisadores da CMU identificaram 18 características de voz que distinguem pacientes COVID-19 positivos e treinaram um modelo para diagnosticar a COVID-19 com uma precisão de 89,1%.","index.faq.aiQ":"Como o algoritmo de IA da Virufy irá detectar a COVID-19?","index.faq.aiA":"Com Baseado nestas pesquisas passadas, Virufy está desenvolvendo um algoritmo de IA que pode ser usado para prever com precisão uma infecção COVID-19 em minutos, baseado em gravações de sons de tosse. Entretanto, ao contrário das pesquisas anteriores sobre tosse COVID-19 que visavam a população dos EUA, a Virufy pretende coletar dados de múltiplos locais em todo o mundo. Como uma iniciativa dirigida por estudantes e com voluntários abrangendo vários países, a Virufy está desenvolvendo um modelo de detecção da COVID-19 com maior inclusão racial e espacial através de dados que incluem uma gama de etnias e diferenças fonológicas específicas da comunidade.","nav.ourApproach":"Nossa abordagem","nav.dashboard":"Dashboard","nav.ourData":"Os nossos dados","nav.ourOrg":"Nossa Organização","nav.inTheNews":"Nas notícias","nav.getInvolved":"SE ENVOLVA","nav.techBehind":"A tecnologia por trás","nav.openData":"Dados abertos","nav.faqs":"FAQs","nav.ourVision":"Nossa visão","nav.ourSupporters":"Nossos apoiadores","nav.ourTeam":"A nossa gente","news.headers.header":"Virufy como visto nas notícias","news.headers.filter":"Filtrar notícias por país","news.news.section2.date":"February 2021","news.news.section2.title":"Esta app busca diagnosticar Covid-19 con sólo toser frente al teléfono","news.news.section2.name":"Forbes","news.news.section2.city":" ","news.news.section2.country":" ","news.news.section2.readMoreLink":"Leia mais...","news.news.section3.date":"January 2021","news.news.section3.title":"COVID-19: Aplicativo Virufy puede diagnosticar el virus mediante el análisis de la tos","news.news.section3.name":"MSN","news.news.section3.city":" ","news.news.section3.country":" ","news.news.section3.readMoreLink":"Leia mais...","news.news.section4.date":"Outubro 2020","news.news.section4.title":"VIRUFY: plataforma que permite detectar si estamos contagiados con COVID-19","news.news.section4.name":"Expreso","news.news.section4.city":"Lima, ","news.news.section4.country":"Peru","news.news.section4.readMoreLink":"Leia mais...","news.news.section5.date":"Maio 2020","news.news.section5.title":"Um jovem embaixador do Japão no mundo jovem tem como objetivo COVID-19 usando a A.I.","news.news.section5.name":"Um Mundo Jovem","news.news.section5.city":"Tokyo, ","news.news.section5.country":"Japão","news.news.section5.readMoreLink":"Leia mais...","news.news.section6.date":"2020","news.news.section6.title":"Embaixadores norte-americanos na linha de frente da resposta da COVID-19","news.news.section6.name":"Um Mundo Jovem","news.news.section6.city":" ","news.news.section6.country":" ","news.news.section6.readMoreLink":"Leia mais...","news.news.section7.date":"Julho 2020","news.news.section7.title":"Embaixadores do Mês de Julho","news.news.section7.name":"Um Mundo Jovem","news.news.section7.city":" ","news.news.section7.country":" ","news.news.section7.readMoreLink":"Leia mais...","news.news.section8.date":"Julho 2020","news.news.section8.title":"Milhares de pessoas assistem aos eventos digitais globais da OYW em Julho: Uma recapitulação do que você perdeu","news.news.section8.name":"Um Mundo Jovem","news.news.section8.city":" ","news.news.section8.country":" ","news.news.section8.readMoreLink":"Leia mais...","news.news.section9.date":"2020","news.news.section9.title":"Um Mundo Jovem Tokyo 2020 Caucus","news.news.section9.name":"Um Mundo Jovem","news.news.section9.city":" ","news.news.section9.country":" ","news.news.section9.readMoreLink":"Leia mais...","news.news.section10.date":"2020","news.news.section10.title":"Apresentação da Virufy a Um Mundo Jovem Yokyo 2020 Cacus","news.news.section10.name":"Um Mundo Jovem","news.news.section10.city":"Tokyo, ","news.news.section10.country":"Japão","news.news.section10.readMoreLink":"Assistir mais...","news.news.section11.date":"2020","news.news.section11.title":"Sons do COVID-19 seminário","news.news.section11.name":"Um Mundo Jovem","news.news.section11.city":" ","news.news.section11.country":" ","news.news.section11.readMoreLink":"Leia mais...","ourApproach.topFold.diagnoseDisease":"IA para diagnosticar doenças de forma rápida e livre","ourApproach.topFold.acrossNations":"Todas as pessoas em todas as nações devem ter acesso rápido e acessível aos cuidados de saúde. Então, estamos usando tecnologia para fazer isso","ourApproach.topFold.usingTechnology":"Por isso, estamos a utilizar tecnologia para o fazer","ourApproach.topFold.algorithmInfo":"Com a ajuda da investigação de ponta das mais prestigiadas instituições mundiais - Stanford, Princeton, Cambridge - estamos a desenvolver um algoritmo de IA que diagnostica com precisão COVID-19 apenas analisando os sons da tosse de uma pessoa.","ourApproach.topFold.readWhitePaper":"LEIA NOSSO RESEARCH PAPER","ourApproach.topFold.wantToLearnMore":"QUER SABER MAIS?","ourApproach.research.universityOfCambridge.title":"Explorando o diagnóstico automático de COVID-19 a partir de dados de sons respiratórios coletivos","ourApproach.research.universityOfCambridge.description":"Pesquisa com milhares de pessoas coletada pela Universidade de Cambridge que usou amostras de tosse e respiração para mostrar como os sons do COVID-19 são discerníveis daqueles em saudáveis ou asmáticos. Seus resultados mostram que mesmo um classificador de aprendizado de máquina binário simples é capaz de classificar sons saudáveis e COVID-19 corretamente. Este trabalho fornece uma base para uma investigação mais aprofundada de como os padrões respiratórios analisados automaticamente podem ser usados como sinais de pré-triagem para auxiliar no diagnóstico de COVID-19.","ourApproach.research.universityOfCambridge.source":"University of Cambridge","ourApproach.research.carnegieMellonUniversity.title":"Detector de voz COVID","ourApproach.research.carnegieMellonUniversity.description":"Um estudo da Carnegie Mellon University teve como objetivo coletar um grande número de amostras de voz para treinar IA para o diagnóstico de COVID. A justificativa por trás do estudo é que \"o som da nossa voz (independentemente do idioma) e os sons que fazemos quando respiramos ou tossimos mudam quando nosso sistema respiratório é afetado. As mudanças variam de mudanças grosseiras e claramente audíveis a minutos mudanças - o que chamamos de \"micro\" assinaturas, que não são audíveis para o ouvinte não treinado, mas estão presentes\"","ourApproach.research.carnegieMellonUniversity.source":"Carnegie Mellon University","ourApproach.research.MIT.title":"Olá Sigma, estou com o Coronavirus? Solicitação de uma nova abordagem de inteligência artificial para apoiar profissionais de saúde que lidam com a pandemia COVID-19.","ourApproach.research.MIT.description":"O Departamento de Engenharia Mecânica do MIT propõe a detecção de casos positivos de COVID por meio da coleta de amostras de tosse por telefone para treinar a inteligência artificial e, posteriormente, construir um algoritmo de diagnóstico. Isso ressalta o interesse de especialistas em nossa ideia.","ourApproach.research.MIT.source":"Massachusetts Institute of Technology (MIT)","ourApproach.research.various.title":"O diagnóstico preliminar ativado por IA para COVID-19 a partir de amostras de tosse por meio de um aplicativo","ourApproach.research.various.description":"O estudo projetado para coletar amostras de tosse para treinar e usar arquitetura de IA que minimiza diagnósticos incorretos. Eles preveem que, no momento em que este artigo foi escrito, seu mecanismo de IA pode distinguir entre tosses de pacientes com COVID-19 e vários tipos de tosses não-COVID-19 com mais de 90% de precisão.","ourApproach.research.various.source":"(Vários)","ourApproach.research.universityOfEngineeringPakistan.title":"A análise de som de tosse para classificação de pneumonia e asma na população pediátrica","ourApproach.research.universityOfEngineeringPakistan.description":"A IA foi usada para distinguir entre tosses de asma e pneumonia, com o objetivo de fornecer atendimento médico a países em desenvolvimento com poucos recursos. Seu método alcançou uma sensibilidade de 89%, especificidade de 100% e Kappa de 0,89. Seus resultados mostram o uso potencial de IA na detecção e diferenciação de sons respiratórios.","ourApproach.research.universityOfEngineeringPakistan.source":"Universidade de Engenharia e Tecnologia do Paquistão","ourApproach.research.imperialCollegeLondon.title":"Um algoritmo baseado em tosse para diagnóstico automático de coqueluche","ourApproach.research.imperialCollegeLondon.description":"Pesquisadores do Imperial College de Lodres coletaram sons de tosse e chiado relacionados à coqueluche, crupe e outras doenças, como bronquite e asma, para treinar IA a fim de detectar coqueluche. Seu algoritmo foi capaz de diagnosticar toda coqueluche com sucesso a partir de gravações de áudio, detectando automaticamente sons de tosse individuais com 92% de precisão e VPP de 97%. Seu resultado apóia o uso de IA como um candidato potencial para diferenciar e diagnosticar sons respiratórios.","ourApproach.research.imperialCollegeLondon.source":"Department of Electrical and Electronic Engineering, Imperial College London","ourApproach.faq.title":"Perguntas Frequentemente Feitas (FAQ)","ourApproach.faq.virufyApp":"Virufy App","ourApproach.faq.virufyApp.whenAndHowQ":"When and how will the app give COVID-19 prediction results?","ourApproach.faq.virufyApp.whenAndHowA":"Our app is currently for data collection only.\n\nWe cannot release a COVID-19 prediction app without public health department approvals in each country and clinical studies to validate the AI technology in local conditions. This process can take some weeks or months depending on the speed of the government partner. Virufy welcomes partnerships from health officials and hospitals to bring the technology for free use to the people and to optimize usage of costly PCR tests only when necessary.","ourApproach.faq.virufyApp.whereDownloadQ":"Where can I download the app? Will it be available for iOS and Android?","ourApproach.faq.virufyApp.whereDownloadA":"The app will be available for download at <a target='_blank' href='https://virufy.org/app'>https://virufy.org/app</a>, as we need government or medical approval in some countries to put our app into the official app stores.\n\nThe app can be connected to and from a smartphone. Thus, it is compatible with any operating system including iOS or Android.","ourApproach.faq.virufyApp.willTheApplicationQ":"Will the application be available for free and worldwide?","ourApproach.faq.virufyApp.willTheApplicationA":"As a 501(c)(3) non-profit organization, our intention is to make the app free for the benefit of low-income countries. However, we may need to charge a nominal fee to support our operations in case we are not able to raise enough funds.","ourApproach.faq.virufyApp.doYouPlanQ":"Do you plan to extend this app in a startup?","ourApproach.faq.virufyApp.doYouPlanA":"Virufy is a non-profit. We may partner with companies if needed to accelerate deployment of the app for the benefit of people.","ourApproach.faq.virufyApp.whenWillTheAppQ":"When will the app be available for my country?","ourApproach.faq.virufyApp.whenWillTheAppA":"Virufy strives to comply with data privacy laws which vary by country. We are very happy to extend to your country if we are able to connect with a pro bono data privacy lawyer to review our privacy policy and consent form.","ourApproach.faq.virufyApp.whatisTheVisionQ":"What is the vision for the Virufy app?","ourApproach.faq.virufyApp.whatisTheVisionA":"Virufy was initially intended as a supplement to tests. We also envision a future where people can easily know their health condition so they do not spread any sicknesses.","ourApproach.faq.virufyApp.whoCanAccessQ":"Who can access the test results? How does the organization try to regulate the range of accessibility? Where are the test results stored?","ourApproach.faq.virufyApp.whoCanAccessA":"Our intention for the predictive apps is for only the user to see their test results since there is a lot of fear around positive results. The data from the test results and data collection will be stored in secure servers.","ourApproach.faq.aboutVirufy":"About Virufy","ourApproach.faq.aboutVirufy.howWasQ":"How was this initiative created?","ourApproach.faq.aboutVirufy.howWasA":"When the pandemic hit, Virufy’s founder, Amil, knew smartphones were omnipresent and that COVID impacted the nose, throat, and lungs. He hypothesized that breathing and cough sounds could be analyzed with machine learning to detect COVID patterns. Wanting to make a positive impact, he orchestrated a clinical study with 362 patients in an esteemed university hospital. The original team of Virufy, beginning with Stanford graduate AI students, expanded to volunteers from universities around the world.\n\nAs a <a target='_blank' href='https://www.oneyoungworld.com/'>One Young World Japan</a> ambassador who has travelled to over a dozen countries, Amil understands the global perspective and how a smartphone-based solution can be used by people all over the world.","ourApproach.faq.aboutVirufy.whatWillQ":"What will your organization do?","ourApproach.faq.aboutVirufy.whatWillA":"Virufy aims to build the world’s largest dataset of COVID cough sounds by generating a movement where millions of people collectively contribute their data to fight our common enemy, COVID. As a 501(c)(3) non-profit startup free of institutional red tape and with a diverse team across 20 countries, we are well positioned to make this happen.\n\nOnce approved by local public health authorities, smartphone app(s) for rapid, no-cost COVID testing will be released in low-income countries. These apps will allow for mass-scale, anonymous testing to slow the virus spread. We hope to unite people across borders in our effort to stop COVID and create a new paradigm for global collaboration.\n\nWe want to create a future where community spread of infectious diseases is greatly reduced, as the world population is empowered by smartphone apps to detect their illnesses early on.","ourApproach.faq.aboutVirufy.howIsVirufyQ":"How is Virufy different from other groups working on similar projects?","ourApproach.faq.aboutVirufy.howIsVirufyA":"Because Virufy is a 501(c)(3) non-profit organization, we are able to recruit highly talented professionals as volunteers. Our team is global, spanning five continents, and our organization thus has global empathy built in. We are not concerned with making profit, so are able to work in developing countries. Our dense networks in Stanford and One Young World grant us access to top echelon contacts in every country of the world. Our model of young professionals empowered by sage advice from senior industry experts leads to rapid, creative activity focused in the right direction.","ourApproach.faq.aboutVirufy.whatPhaseQ":"What phase of the investigation are you at? Is there a deadline to participate?","ourApproach.faq.aboutVirufy.whatPhaseA":"We have put considerable effort to form partnerships, build our mobile app, register our California non-profit entity, and build our policies for compliance with data privacy laws across 7 countries.\n\nOur data collection app is at the breakthrough stage, as have addressed the majority of healthcare data privacy and technical concerns to allow for launch. We have already gotten data privacy, information security, and UI/UX in place for our data collection mobile app, along with a scalable backend AWS infrastructure.\n\nWe anticipate large volumes of data collection in 2021 and intend to drive collaborative AI development efforts to build the solution. There is no deadline, and we always welcome more cough data as it improves the AI algorithm.","ourApproach.faq.aboutVirufy.whatIsUniqueQ":"What is unique about Virufy from other projects?","ourApproach.faq.aboutVirufy.whatIsUniqueA":"We are youth run, with a diverse and global team from across 15 countries and 25 universities. We are guided by expert advisors from universities, non-profits, and businesses around the world. Our multidisciplinary team has expertise in data privacy, machine learning, medicine, information security, and mobile app development. Our One Young World network allows us to connect with trusted partners in every country.\n\nWe welcome all, and being a 501(c)(3) non-profit allows for volunteers to join. As a volunteer run non-profit, we are independent and have less red tape. We also have pro bono access to legal and data privacy advice for proper deployment.","ourApproach.faq.aboutVirufy.howMuchInvestmentQ":"How much investment was made to make the Virufy project possible?","ourApproach.faq.aboutVirufy.howMuchInvestmentA":"More than 200 volunteers have put thousands of hours into making the project possible. Companies including Slack and JotForm have supported us with free software and cloud credits as COVID responders. Other expenses such as email services and cloud compute have been paid out of the founder Amil’s savings but are only a few thousand dollars.\n\nWe believe that if we are successful, our cloud compute costs will increase, but we will be able to attract ample grant funding and private donations, and thus are thinking to rely solely on that.","ourApproach.faq.aboutVirufy.isVirufyAnonProfitQ":"Is Virufy a non-profit?","ourApproach.faq.aboutVirufy.isVirufyAnonProfitA":"Virufy is a California nonprofit corporation operating through a fiscal sponsorship with Players Philanthropy Fund, a Maryland charitable trust recognized by IRS as a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code (Federal Tax ID: 27-6601178). Contributions to Virufy are tax-deductible to the fullest extent of the law.","ourApproach.faq.aboutVirufy.whatAreUniversitiesQ":"What are the participating universities?","ourApproach.faq.aboutVirufy.whatAreUniversitiesA":"Virufy is not officially affiliated with any university.\n\nHowever, we are a Stanford University <a target='_blank' href='https://responselab.stanford.edu/projects.html'>COVID-19 Response Innovation Lab project</a>, have participated in <a target='_blank' href='https://h4r.stanford.edu/'>Stanford’s Hacking</a>   for Recovery startup accelerator, and have also been featured across various <a target='_blank' href='https://www.oneyoungworld.com/'>One Young World platforms</a>.\n\n\nOur team includes students and alumni from more than 25 universities including UC Berkeley, Harvard, and Princeton.","ourApproach.faq.aboutAI":"About Artificial Intelligence Algorithm","ourApproach.faq.aboutAI.whyQ":"Why are COVID-19 coughs distinguishable?","ourApproach.faq.aboutAI.whyA":"Similar to other respiratory diseases, COVID-19 damages the throat and lungs, creating detecable differences in cough patterns. Consequently, cough sounds can be analyzed to detect COVID-19​.​ Globally, this idea is being actively researched by several prestigious institutions, including Carnegie Mellon (CMU), MIT, and Cambridge. For example,research done by University of Cambridge showed that a simple binary machine learning classifier is able to classify COVID-19 positive patients through breathing and coughing sounds with high acurracy. Similarly, researchers at CMU identified 18 voice features that distinguish positive COVID-19 patients and trained an academic model to detect COVID-19 with high accuracy.","ourApproach.faq.aboutAI.howWillQ":"How will Virufy’s AI algorithm detect COVID-19?","ourApproach.faq.aboutAI.howWillA":"Based on past research, Virufy is developing an AI algorithm that can be used to accurately predict a COVID-19 infection within minutes based on recordings of cough sounds. However, as opposed to previous COVID-19 cough research that targeted the US population, Virufy aims to collect data from multiple sites across the globe. As a student-run initiative with volunteers spanning several countries, Virufy is developing a COVID-19 diagnostic model with greater racial and spatial inclusivity through data that includes a range of ethnicities and community-specific phonological differences.","ourApproach.faq.aboutAI.howDoesQ":"How can the app help prevent coronavirus infections?","ourApproach.faq.aboutAI.howDoesA":"By empowering everyone to know their risk status for COVID and other diseases, the potential for the spread of unknown viruses will decrease considerably. Early detection will allow for people to self-isolate and take measures to heal from the virus faster.\n\nMeanwhile, nurses in developing countries can use the app to check if a patient has COVID, thus reducing the need to use expensive PCR test kits. People can also check themselves anytime they feel they have a COVID symptoms to confirm whether they need to go to the doctor for a check up or test for COVID.","ourApproach.faq.aboutAI.howDoYouQ":"How do you measure our percentage of effectiveness, and is this measured in clinical studies?","ourApproach.faq.aboutAI.howDoYouA":"Please see <a target='_blank' href='https://virufy.org/paper'>https://virufy.org/paper</a> and <a target='_blank' href='https://virufy.org/research.html'>https://virufy.org/research.html</a>  for details about our research.","ourApproach.faq.aboutAI.areSmartPhoneQ":"Are smartphone microphones reliable enough to be used for detection?","ourApproach.faq.aboutAI.areSmartPhoneA":"Yes, the results from 3500 people from 20 countries with many different smartphones show that microphones are indeed able to capture COVID-19 signatures.","ourApproach.faq.aboutAI.willPerformanceQ":"Will the performance of the AI model in different environments remain unaffected?","ourApproach.faq.aboutAI.willPerformanceA":"Ideally, we would want users to follow the instructions on the app on how to record their cough. However, we can use a technique called data augmentation to make the algorithm work in all types of situations if needed.","ourApproach.faq.aboutAI.whatWasQ":"What was the main difficulty in collecting and processing data? Was there any region where artificial intelligence was less accurate, for example?","ourApproach.faq.aboutAI.whatWasA":"The process is slow and cumbersome when collecting from hospitals, requiring clinical study forms and IRB approvals. With supervision from Stanford medical advisors, we went through this process for two hospitals in South Asia and are currently in discussions with hospitals in South America and Africa.\nFor collecting directly from users, we spent significant efforts with pro bono expert lawyers to ensure compliance with data privacy laws, including LGPD.\nAs described in our <a target='_blank' href='https://virufy.org/paper'>research paper</a>, some of the difficulties we found in processing data included excessive background noises and incorrect cough recordings submitted by users, which required the AI developers to manually clean the audio samples before training AI models.","ourApproach.faq.aboutAI.hasTecnologyQ":"Has the technology been validated yet?","ourApproach.faq.aboutAI.hasTecnologyA":"Yes, various groups across the world have validated that coughs contain detectable patterns signifying the presence of COVID-19. We believe that rollout of the technology is just a matter of time and collaboration. As outlined in our research paper, we have independently shown that the COVID cough signature generalizes across continents and between clinical and crowdsourced datasets.\n\nWe have already done IRB-approved clinical studies in hospitals in two countries and are currently seeking approvals in Africa, Latin America, and South Asia for clinical studies through private hospital executive and top-level governmental connections.","ourApproach.faq.aboutAI.canAsymptomaticQ":"Can asymptomatic cases be detected?","ourApproach.faq.aboutAI.canAsymptomaticA":"Yes, asymptomatic detection has been shown in research by MIT and other groups. It is especially important for people in their 20s and 30s who are more likely to be asymptomatic.","ourApproach.faq.aboutAI.willTheAppQ":"Will the application use artificial intelligence developed by third parties or created just for this purpose?","ourApproach.faq.aboutAI.willTheAppA":"Virufy has its own AI research team and is open to collaboration and integration of AI algorithms from other research groups.","ourApproach.faq.aboutAI.whatAreYourPlansQ":"What are your plans for Virufy after the COVID-19 vaccine?","ourApproach.faq.aboutAI.whatAreYourPlansA":"We anticipate that low-income countries will not have the financial resources and medical infrastructure to vaccinate their population and that rapid, equitable COVID-19 testing will still be important to control the pandemic, especially in those countries. Additionally, from our discussions with senior vaccine industry experts, it is unclear how effective the new COVID-19 vaccines will be in the long-term and also fear that COVID will remain a seasonal disease similar to other coronaviruses such as the common cold and flu.","ourApproach.faq.aboutAI.whatAreYourPlansControlQ":"What are your plans for Virufy after COVID-19 is under control?","ourApproach.faq.aboutAI.whatAreYourPlansControlA":"Virufy aims to bring an end to the spread of various communicable diseases in low-income countries through widespread, smartphone-based testing which can be used whenever a community feels at risk of virus spread. We anticipate that the same artificial intelligence technology can be adapted to detect other coronaviruses, including the common cold and influenza. This can reduce the unnecessary burden on healthcare systems and chemical-based diagnosis for diseases which can be detected by AI.","ourApproach.faq.aboutFinances":"About Finances and Donations","ourApproach.faq.aboutFinances.doIneedQ":"Do I need to make any financial contribution to donate my cough?","ourApproach.faq.aboutFinances.doIneedA":"No.","ourApproach.faq.aboutFinances.howDoIQ":"How do I record my cough and submit it to Virufy?","ourApproach.faq.aboutFinances.howDoIA":"Virufy is currently only collecting coughs from certain countries, which can be found in our app: <a target='_blank' href='https://virufy.org/app'>https://virufy.org/app</a>","ourApproach.faq.aboutFinances.doIneedToHaveQ":"Do I need to have coughing symptoms to donate my cough?","ourApproach.faq.aboutFinances.doIneedToHaveA":"No, the app is also compatible with a forced cough.","ourApproach.faq.aboutFinances.howManyQ":"How many donors have you had in total?","ourApproach.faq.aboutFinances.howManyA":"We have more than 5,000 cough recordings from over 10 countries, mostly in South America and South Asia. Some of these are clinical, and others are contributed directly by individuals in our app.","ourApproach.faq.aboutFinances.whatAreQ":"What are the operational expenses for the organization?","ourApproach.faq.aboutFinances.whatAreA":"We are currently completely volunteer run. Our main budget requirements are for marketing to complete data collection. We would also need money for computation later on after scaling to a large user base.","ourApproach.faq.aboutFinances.doesTheTeamQ":"Does the team get funding? If so, where and how much? What is it used on?","ourApproach.faq.aboutFinances.doesTheTeamA":"We do not have funding yet, as we are just starting to apply for grants after recently obtaining 501(c)(3) status.","ourApproach.faq.privacyDetails":"Privacy details","ourApproach.faq.privacyDetails.howWillQ":"How will Virufy securely store my data?","ourApproach.faq.privacyDetails.howWillA":"We use JotForm and Amazon Web Services (AWS) for research study data collection. JotForm and AWS store the data in a secure application with restricted access and controls. Your data will be stored with JotForm or AWS until it is downloaded by us. We will store the data in a database with restricted access. If you would like more information about how JotForm and AWS store your data, please visit their respective privacy policies at <a target='_blank' href='https://www.jotform.com/privacy/'>https://www.jotform.com/privacy/</a> and <a target='_blank' href='https://aws.amazon.com/en/privacy/'>https://aws.amazon.com/en/privacy/</a>. If you would like to learn more, please refer to the Virufy privacy policy.","ourApproach.faq.privacyDetails.isMyPrivacyQ":"Is my privacy ever at risk of being exposed when I donate my cough to Virufy?","ourApproach.faq.privacyDetails.isMyPrivacyA":"Our strong legal and information security teams have developed a DPIA to address potential risks and threats for your privacy. We will only store your personal data in an anonymized form (whereas you cannot be identified in any way) and in a secure database with restricted access. If you would like to learn more please refer to the <a target='_blank' href='https://virufy.org/privacy_policy.html'>Virufy Privacy Policy</a>.","ourApproach.faq.privacyDetails.doesVirufyHaveQ":"Does Virufy have a privacy policy and cookie policy?","ourApproach.faq.privacyDetails.doesVirufyHaveA":"Virufy takes the privacy and protection of your personal information seriously. Our legal team has prepared a detailed Privacy Policy and Cookie Policy to protect the personal information you share with us through use of our website, participation in our cough donation study, contacting us, and volunteer applications.","ourApproach.faq.privacyDetails.willMyDataQ":"Will my data be shared with third parties?","ourApproach.faq.privacyDetails.willMyDataA":"If you opt-in to share your contact information (e.g., email and phone number) with us, we will not distribute any of this personal identifiable information to any third party. However, we may share your anonymized information, such as your cough sounds, with third parties in order to accelerate global research efforts to stop the COVID-19 pandemic and other future spreads of disease. More details can be found in our <a target='_blank' href='https://www.jotform.com/privacy/'>Privacy Policy</a> and the data collection study <a target='_blank' href='https://virufy.org/us/study_consent.pdf'>Consent Form</a>.","ourApproach.faq.otherDetails":"Other details","ourApproach.faq.otherDetails.howCanQ":"How can I support Virufy more?","ourApproach.faq.otherDetails.howCanA":"You can join our team today and look at the <a target='_blank' href='https://virufy.org/join.html'>join page</a> for more information. You can also support us at <a target='_blank' href='https://gofundme.com/virufy'>GoFundMe</a>. You can also contact us for partnership.","ourApproach.faq.otherDetails.howDoesDistributionQ":"How does distribution work, and how will Virufy become more widespread?","ourApproach.faq.otherDetails.howDoesDistributionA":"The app will be offered for the benefit of people in low-income countries and will likely market itself and spread quickly.","ourApproach.faq.otherDetails.inHowManyQ":"In how many countries has data collection for Virufy already taken place? In addition to Latin America, does the organization have another focus at this time?","ourApproach.faq.otherDetails.inHowManyA":"We have collected data from the countries listed on our <a target='_blank' href='https://virufy.org/app.html'>app</a>. Latin America is our main focus region right now.","ourApproach.faq.otherDetails.howHasQ":"How has the response of the people been?","ourApproach.faq.otherDetails.howHasA":"All of our customer surveys and media responses have suggested that people greatly appreciate the existence of the app and support our cause.","ourApproach.faq.otherDetails.willYouQ":"Will you collaborate with governments for data collection? If so, what will it be like?","ourApproach.faq.otherDetails.willYouA":"Currently, we do not have any collaboration agreements with governments for data collection. However, we are open to partnerships with governments to increase cough data collection through marketing or clinical means. Additionally, we would like to accelerate approval for the deployment of the AI detection app in low-income countries which could involve introductions and partnerships to local medical AI companies, universities, and research groups.","ourApproach.faq.otherDetails.doesYourQ":"Does your product need regulatory approval (e.g., FDA)? If so, what is the approval process? What is your plan to get approved, and how much time and money will it take?","ourApproach.faq.otherDetails.doesYourA":"We are compliant with data privacy regulations in several countries across 3 continents. The Health Insurance Portability and Accountability Act (HIPAA) does not apply to us.\n\nAs we are not providing predictions to individuals in the US, FDA approval is not needed.","ourApproach.faq.otherDetails.WhatIfiQ":"What if I have more questions?","ourApproach.faq.otherDetails.WhatIfiA":"More details can be found in our full <a target='_blank' href='https://www.jotform.com/privacy/'>Privacy Policy</a>, <a target='_blank' href='https://virufy.org/cookie_policy.html'>Cookie Policy</a>, and consent form which is embedded in the <a target='_blank' href='https://virufy.org/app'>data collection app</a>.\n\nFor questions related to the data collection study, please email us at <a href='mailto:study@virufy.org'>study@virufy.org</a>.\nFor data related queries, we can be contacted at <a href='mailto:open-data@virufy.org'>open-data@virufy.org</a>.\nFor all other inquiries, you may reach us at <a href='mailto:info@virufy.org'>info@virufy.orgg</a>.","ourApproach.faq.missionCategory":"Missão","ourApproach.faq.nonprofitQ":"O Virufy é uma organização sem fins lucrativos?","ourApproach.faq.nonprofitA":"O Virufy é uma corporação sem fins lucrativos que visa o benefício público registrada na Califórnia. No entanto, a aprovação do nosso status oficial segundo a legislação americana, relacionada a seção 501(c)(3), pode demorar até a metade de 2021 enquanto a Internal Revenue Servise (IRS) (Agência federal americana que funciona como serviço de receita do governo) está sobrecarregada em decorrência do COVID-19.","ourApproach.faq.postVaccineQ":"Quais os seus planos para o Virufy após a vacina de COVID-19?","ourApproach.faq.postVaccineA":"Nós antecipamos que países de baixa renda não possuirão os recursos financeiros e a infraestrutura médica para vacinar a sua população e que a testagem ágil e equitativa para COVID-19 continuará importante para controlar a pandemia, especialmente naqueles países.","ourApproach.faq.postControlQ":"Quais os seus planos para o Virufy depois que a COVID-19 estiver sobre controle?","ourApproach.faq.postControlA":"O Virufy visa trazer ao fim o disseminar de várias doenças contagiosas por meio da testagem de forma abrangente baseada em dispositivos smartphones que podem ser usada sempre que a comunidade esteja em perigo da disseminação de um vírus. Nós antecipamos que a mesma tecnologia de inteligência artificial pode ser adaptada para detectar outras coronaviroses, incluindo o resfriado comum e a influenza.","ourApproach.faq.detectionCategory":"Tecnologia","ourApproach.faq.distinguishableQ":"Como as tosses de COVID-19 podem ser distinguidas?","ourApproach.faq.distinguishableA":"Semelhante a todas as outras doenças respiratórias, o COVID-19 cria uma assinatura respiratória única na garganta e nos pulmões que é distinta de outras infecções respiratórias que produzem tosse úmida. Consequentemente, foi sugerido que os sons da tosse podem ser analisados para detectar COVID-19. Globalmente, essa ideia está sendo ativamente pesquisada por várias instituições de prestígio, incluindo CMU, MIT e Cambridge. Por exemplo, uma pesquisa crowdsource feita pela University of Cambridge mostrou que um classificador de aprendizado de máquina binário simples é capaz de classificar pacientes positivos para COVID-19 por meio de sons de respiração e tosse com alta precisão (AUC = 0,7). Da mesma forma, os pesquisadores da CMU identificaram 18 características de voz que distinguem pacientes COVID-19 positivos e treinaram um modelo para diagnosticar COVID-19 com uma precisão de 89,1%.","ourApproach.faq.diagnosisQ":"Como o Algoritmo AI de Virufy prevê um diagnóstico COVID-19?","ourApproach.faq.diagnosisA":"Com base nesta pesquisa anterior, Virufy está desenvolvendo um algoritmo de IA que pode ser usado para prever com precisão uma infecção por COVID-19 em minutos com base em gravações de sons de tosse. No entanto, ao contrário da pesquisa anterior de tosse COVID-19 que teve como alvo a população dos EUA, Virufy visa coletar dados de vários locais em todo o mundo. Como uma iniciativa dirigida por estudantes com voluntários em vários países, Virufy está desenvolvendo um modelo de diagnóstico COVID-19 com maior inclusão racial e espacial por meio de dados que incluem uma variedade de etnias e diferenças fonológicas específicas da comunidade.","ourApproach.faq.performanceQ":"O desempenho do modelo de IA em diferentes smartphones não será afetado?","ourApproach.faq.performanceA":"O ideal é que os usuários sigam as instruções do aplicativo que explicam como registrar a tosse. No entanto, podemos usar uma técnica chamada aumento de dados para fazer o algoritmo funcionar em todos os tipos de cenários, se necessário.","ourApproach.faq.privacyCategory":"Privacidade de dados","ourApproach.faq.dataStorageQ":"Como o Virufy vai guardar os meus dados de forma segura?","ourApproach.faq.dataStorageA":"Usamos JotForm e Amazon Web Services (AWS) para coleta de dados de estudo de pesquisa. JotForm e AWS armazenam os dados em um aplicativo seguro com acesso e controles restritos. Seus dados serão armazenados com JotForm ou AWS até que sejam baixados por nós. Nós iremos armazenar os dados em um banco de dados com acesso restrito. Se você quiser mais informações sobre como a Jotform e a AWS armazenam seus dados, visite suas respectivas políticas de privacidade em <a target='_blank' href='https://www.jotform.com/privacy/'>https://www.jotform.com/privacy/</a> e <a target='_blank' href='https://aws.amazon.com/en/privacy'>https://aws.amazon.com/en/privacy/</a>. Se desejar saber mais, consulte a política de privacidade da Virufy.","ourApproach.faq.privacyThreatsQ":"A minha privacidade corre o risco de ser exposta quando doo a minha tosse para o Virufy?","ourApproach.faq.privacyThreatsA":"Nossos fortes times legais e de segurança da informação desenvolveram um Relatório de Impacto à proteção de Dados Pessoais (do inglês, DPIA), para endereçar potenciais riscos e ameaças a sua privacidade. Nós armazenaremos seus dados pessoais em uma forma que nos permita te identificar por um período máximo de 4 (quatro) meses em uma base de dados segura com acesso restrito. Após os 4 (quatro) meses, nós separaremos todas aquelas informações dos seus dados pessoais (a exemplo do seu nome e informações de contato) e agregaremos isto com os dados de outras pessoas, de forma que você não possa de forma razoavel ser identificado enquanto indivíduo. Para evitar dúvidas, o que nós reteremos no longo prazo serão dados biométricos e de saúde de forma anonimizada, como gravações de tosse, para a finalidade de pesquisa futura sobre viroses e outras condições médicas. Se você desejar saber mais por favor visite a Política de Privacidade da Virufy.","ourApproach.faq.privacyPolicyQ":"O Virufy possui uma Política de Privacidade e uma Política de Cookies?","ourApproach.faq.privacyPolicyA":"O Virufy leva a sério a sua privacidade, e o nosso time legal preparou uma Política de Privacidade detalhada e uma Política de Cookies para proteger os dados pessoais que você compartilhe conosco por meio do uso do site da web, da participação em nosso estudo com a doação de tosse, nos contatando e aplicando para o voluntariado.","ourApproach.faq.thirdPartiesQ":"Os meus dados pessoais serão compartilhados por terceiros?","ourApproach.faq.thirdPartiesA":"Se você optar por compartilhar suas informações de contato (e.g., email e número de telefone celular) conosco, nós não iremos distribuir essas informações identificáveis para nenhum terceiro, mesmo que para propósitos de pesquisa, sem o seu consentimento explícito. No entanto, nós compartilharemos seus dados pessoais anonimizados, como os sons da sua tosse, com terceiros de forma a acelerar os esforços de pesquisa globais de parar a pandemia do COVID-19 e outras futuras disseminações de doenças. Mais detalhes podem ser encontrados em nossa Política de Privacidade e no Formulário de Consentimento Explícito para Coleta de Dados Pessoais e para Participar na Pesquisa.","ourApproach.faq.validTechnologyQ":"A tecnologia já foi validada?","ourApproach.faq.validTechnologyA":"Sim, vários grupos ao redor do mundo tem validado que tosses contém padrões detectáveis que significam a presença de COVID-19. Nós acreditamos que a implantação dessa tecnologia é só uma questão de tempo e colaboração. Mais detalhes podem ser encontrados na nossa página de pesquisa. Você também pode ler acerca dos nossos achados mais recentes em nosso artigo de pesquisa.","ourApproach.faq.financeCategory":"Financeiro","ourApproach.faq.financialContributionQ":" Preciso fazer uma contribuição financeira se estiver doando minha tosse?","ourApproach.faq.financialContributionA":"Não.","ourApproach.faq.appCostQ":"Os usuários precisarão pagar para usar o App?","ourApproach.faq.appCostA":"Enquanto organização sem fins lucrativos a nossa intenção é a de fazer um App gratuito para todos, especialmente em países de baixa renda. No entanto, nós talvez precisemos cobrar uma taxa nominal para o suporte de nossas operações no caso em que não consigamos arrecadar fundos suficientes.","ourApproach.faq.generalCategory":"Geral","ourApproach.faq.moreQuestionsQ":"E se eu tiver mais perguntas?","ourApproach.faq.moreQuestionsA":"Mais detalhes podem ser encontrados em nossas Política de Privacidade, Política de Cookies, e Formulário de Consentimento que estão incutidos no nosso App de coleta de dados. Para questões relacionadas ao estudo de coleta de dados, por favor nos contate por meio do email <a href='mailto:study@virufy.org'>study@virufy.org</a>. Para consultas relacionadas a dados, nós podemos ser contatados através do email open-data@virufy.org . Para quaisquer outras dúvidas, você pode entrar em contato por meio do email <a href='mailto:info@virufy.org'>info@virufy.org</a>","OYW.headers.header":"Virufy & One Young World","OYW.headers.sub-header":"Virufy is honored to extend a special invitation to all One Young World ambassadors around the world to join our team and contribute to stop COVID-19 quickly. <br/><b>Please visit our <a target='_blank' href='/available-roles'>Join Page</a> to apply!</b>","OYW.section1.header":"Virufy is inspired by One Young World!","OYW.section1.sub-header":"Virufy has been featured on various OYW platforms, including in the Americas and Japan, <a target='_blank' href='https://oywj.org/ambassadors-in-action/2020/05/oywj-ambassador-targets-covid-19-using-ai/' class='text-primary'> ambassadors in action </a>, and <a target='_blank' href='https://www.oneyoungworld.com/north-american-ambassadors-frontlines-covid-19-response' class='text-primary'> ambassadors on the frontline for COVID-19 response </a>. We are also collaborating with OYW coordinating ambassadors across various regions for outreach efforts. Please stay tuned as we update this page!","OYW.section2.header":"Focused on global impact","OYW.section2.sub-header":" Collect data and provide equitable solutions for people in developing countries across the world.","OYW.section2.youth":"Youth led","OYW.section2.youth-des":"Our growing team is led by youth from over a dozen countries and are advised by global leaders.","OYW.section2.ambassador":"Ambassador driven","OYW.section2.ambassador-des":"Our organization structure matches One Young World with youth ambassadors leading operations in each country, with regional coordinating ambassadors.","OYW.section2.diverse":"Diverse representation","OYW.section2.diverse-des":"Our team has representation from over 25 universities and 15 countries and includes more than 10 One Young World ambassadors.","OYW.ambassador.header":"OYW Ambassadors","OYW.ambassador.ambassador-list.amil.name":"Amil Khanzada","OYW.ambassador.ambassador-list.amil.description":"OYW Ambassador Japan","OYW.ambassador.ambassador-list.annelisse.name":"Annelisse Torrez Daza","OYW.ambassador.ambassador-list.annelisse.description":"OYW Ambassador Bolivia","OYW.ambassador.ambassador-list.gonzalo.name":"Gonzalo Roiffe","OYW.ambassador.ambassador-list.gonzalo.description":"OYW Ambassador Argentina","OYW.ambassador.ambassador-list.jason.name":"Jason Pareja Jauregui","OYW.ambassador.ambassador-list.jason.description":"OYW Ambassador Peru","OYW.ambassador.ambassador-list.katherine.name":"Katherine Thalia Ortiz León","OYW.ambassador.ambassador-list.katherine.description":"OYW Ambassador Peru","OYW.ambassador.ambassador-list.marcos.name":"Marcos Deza","OYW.ambassador.ambassador-list.marcos.description":"OYW Ambassador Argentina","OYW.ambassador.ambassador-list.nathan.name":"Nathan Thomas","OYW.ambassador.ambassador-list.nathan.description":"OYW Ambassador USA","OYW.ambassador.ambassador-list.sebastian.name":"Sebastian Pedraza","OYW.ambassador.ambassador-list.sebastian.description":"OYW Ambassador Colombia","OYW.ambassador.ambassador-list.veronica.name":"Verónica Guzmán Quilaqueo","OYW.ambassador.ambassador-list.veronica.description":"OYW Ambassador Chile","OYW.ambassador.ambassador-list.madhav.name":"Madhav Datt","OYW.ambassador.ambassador-list.madhav.description":"OYW Ambassador India","OYW.ambassador.ambassador-list.yulie.name":"Yulie Qiao","OYW.ambassador.ambassador-list.yulie.description":"OYW Ambassador USA","OYW.testimonials.title":"Testimonials","OYW.testimonials.intro":"Our team is led by students dedicated to social good from reputable institutions like Stanford, Princeton, and One Young World. We have strong trust in members of the One Young World community and warmly welcome any ambassadors interested to pitch in.","OYW.testimonials.annelisse":"Having suffered through COVID myself along with all of my family in a underprivileged country, I knew instantly that I could make a difference and prevent others from facing my same fate by joining Virufy.","OYW.testimonials.sebastian":"Virufy unites the power of youth and technology to transform the world. We hope that this solution will reach the whole world and that it will become a support for doctors, especially in low-income countries.","OYW.testimonials.gonzalo":"Virufy will impact globally, no matter the users' background or social status. This is what changing the status quo feels like.","OYW.testimonials.marcos":"I think that Virufy will develop a very accurate solution and this will be useful for the entire world in every industry. So I encourage everyone to take some minutes and contribute with us.","privacy_policy.headers.header":"Política de privacidade","privacy_policy.headers.sub-header":"Por favor veja a política de privacidade abaixo que corresponde ao território que você está agora.","privacy_policy.countries.argentina":"Argentina","privacy_policy.countries.arg_policy":"Política de Privacidad","privacy_policy.countries.bolivia":"Boliva","privacy_policy.countries.bol_policy":"Política de Privacidad","privacy_policy.countries.brazil":"Brazil","privacy_policy.countries.brazil_policy":"Política de Privacidade","privacy_policy.countries.colombia":"Colombia","privacy_policy.countries.col_policy":"Política de Privacidad","privacy_policy.countries.mexico":"Mexico","privacy_policy.countries.mex_policy":"Aviso De Privacidad","privacy_policy.countries.peru":"Peru","privacy_policy.countries.peru_policy":"Política de Privacidad","privacy_policy.countries.us":"United States","privacy_policy.countries.us_policy":"Privacy Policy","privacy_policy.countries.eu":"Europe","privacy_policy.countries.eu_policy":"Privacy Policy","team.supportersSection.header":"Os nossos apoiantes","team.supportersSection.supporterText":"Virufy is a <a target=\"_blank\" rel=\"noreferrer\" href=\"\" class=\"underline\"/>Stanford COVID-19 Response Innovation Lab</a> project and is also featured in <a target=\"_blank\" rel=\"noreferrer\" href=\"\" class=\"underline\"/>One Young World</a>","team.teamSection.header":"A nossa equipa","team.teamSection.teamLeadText":"A equipa lidera","team.teamSection.advisorText":"Consultivo","team.teamSection.oyw":"One Young World","team.teamSection.leadership.amil.name":"Amil Khanzada","team.teamSection.leadership.amil.description":"Um Jovem Embaixador da Paz Mundial\nEx-alunos, UC Berkeley Ciência da Computação","team.teamSection.leadership.amil.title":"Fundador e CEO","team.teamSection.leadership.ravel.name":"Ravel Charles","team.teamSection.leadership.ravel.description":"Engenheiro de soluções de nuvem, Google\nMestrado em Estudos Profissionais em Segurança de Dados,Universidade Northeastern","team.teamSection.leadership.ravel.title":"Líder de Equipe Infosec","team.teamSection.leadership.matheus.name":"Matheus Galiza","team.teamSection.leadership.matheus.description":"Comité de Políticas Públicas\nJovenes Iberoamericanos\nM.A. Relações Internacionais, Universidade Federal da Paraíba","team.teamSection.leadership.matheus.title":"Gestor de Divulgação Comunitária do Brasil","team.teamSection.leadership.maisie.name":"Maisie Mora","team.teamSection.leadership.maisie.description":"Universidade Estadual de San Diego","team.teamSection.leadership.maisie.title":"UX team lead","team.teamSection.leadership.jonatan.name":"Jonatan Jaskilioff","team.teamSection.leadership.jonatan.description":"CTO - XOOR","team.teamSection.leadership.jonatan.title":"Chefe de Equipa de Aplicações Móveis","team.teamSection.leadership.marcos.name":"Marcos Deza","team.teamSection.leadership.marcos.description":"One Young World do Mundo Argentina\nM.A. Public Relations, Ott Educación Superior","team.teamSection.leadership.marcos.title":"Líder em Comunicações Digitais na América Latina","team.teamSection.leadership.yoonju.name":"Yoonju Hwang","team.teamSection.leadership.yoonju.description":"Desenvolvedor de site e app móvel\nB.Tech., CUNY NYC College of Technology","team.teamSection.leadership.yoonju.title":"Líder de Equipe de desenvolvimento web","team.teamSection.leadership.gunvant.name":"Gunvant Chaudhari","team.teamSection.leadership.gunvant.description":"Pesquisador de Big Data em Radiologia\nM.D. Student, UC San Francisco","team.teamSection.leadership.gunvant.title":"Líder de equipe de IA","team.teamSection.leadership.jason.name":"Jason Pareja Jauregui","team.teamSection.leadership.jason.description":"Embaixador Coordenador do One Young World América Latina\nGraduate, MIT Sloan School of Management","team.teamSection.leadership.jason.title":"Líder de divulgação comunitária do Peru","team.teamSection.leadership.sebastian.name":"Sebastian Pedraza","team.teamSection.leadership.sebastian.description":"Embaixador do One Young World Colômbia\nMembro do Comitê Diretivo YPARD\nCiência Política e Gestão Pública, International University of La Rioja","team.teamSection.leadership.sebastian.title":"Líder de divulgação comunitária da Colômbia","team.teamSection.leadership.amelie.name":"Amelie Azim-Khan","team.teamSection.leadership.amelie.description":"Embaixador da Juventude, Europa e Reino Unido","team.teamSection.leadership.amelie.title":"Wycombe Abbey","team.teamSection.leadership.kitan.name":"Kitan Fasuyi","team.teamSection.leadership.kitan.description":"Gestor de productos/proyectos\nEpic","team.teamSection.leadership.kitan.title":"Director de Proyectos Globales","team.teamSection.leadership.alfonso.name":"Alfonso Assaf","team.teamSection.leadership.alfonso.description":"Ex-consultor sénior, Deloitte\nB.A. Economics, Universidad del CEMA","team.teamSection.leadership.alfonso.title":"Gestor de Divulgação da Comunidade Argentina","team.teamSection.leadership.zach.name":"Zach Lawless","team.teamSection.leadership.zach.description":"Cientista de Dados Sênior\nUniversidade de Washington","team.teamSection.leadership.zach.title":"Lider de Time MLOps","team.teamSection.leadership.colleen.name":"Colleen Wang","team.teamSection.leadership.colleen.description":"Author of Roses Watered by a Robot’s Tears","team.teamSection.leadership.colleen.title":"Fundraising Team Lead","team.teamSection.leadership.ahmed.name":"Ahmed Fakhry","team.teamSection.leadership.ahmed.description":"Artificial Intelligence Researcher\nAlexandria University","team.teamSection.leadership.ahmed.title":"ML Models Team Lead","team.teamSection.advisors.kara.name":"Kara Meister, M.D.","team.teamSection.advisors.kara.description":"Professor Assistente Clínico, Otorrinolaringologia\nEscola de Medicina de Stanford","team.teamSection.advisors.kara.title":"Conselheiro médico","team.teamSection.advisors.jure.name":"Jure Leskovec","team.teamSection.advisors.jure.description":"Cientista-Chefe - Pinterest\nProfessor Associado de IA, AI\nEscola de Engenharia de Stanford","team.teamSection.advisors.jure.title":"Conselheiro de Inteligencia Artificial","team.teamSection.advisors.matt.name":"Matt Prusak","team.teamSection.advisors.matt.description":"Chief Business Officer, Curative Alumnus\nStanford Graduate School of Business","team.teamSection.advisors.matt.title":"Conselheiro Executivo","team.teamSection.advisors.rok.name":"Rok Sosic","team.teamSection.advisors.rok.description":"Engenheiro de Investigação Sénior\nEscola de Engenharia de Stanford","team.teamSection.advisors.rok.title":"Consultor de Inteligência Artificial","team.teamSection.advisors.rafi.name":"Rafi Azim-Khan","team.teamSection.advisors.rafi.description":"Sócio - Lei de Pillsbury\nVale do Silício & Europa","team.teamSection.advisors.rafi.title":"Conselheiro Jurídico Executivo","team.teamSection.advisors.richard.name":"Richard Nall","team.teamSection.advisors.richard.description":"O Jardim da Marca - CEO","team.teamSection.advisors.richard.title":"Director de Marketing","team.teamSection.advisors.madhav.name":"Madhav Datt","team.teamSection.advisors.madhav.description":"Fundado - Green the Gene\nEx-Representante Global para Jovens - UN EP","team.teamSection.advisors.madhav.title":"Conselheiro Executivo","team.teamSection.advisors.nathan.name":"Nathan Thomas","team.teamSection.advisors.nathan.description":"Embaixador do One Young World\nFounder e CEO - All We Are","team.teamSection.advisors.nathan.title":"Conselheiro Executivo","team.teamSection.advisors.melissa.name":"Melissa Dyrdahl","team.teamSection.advisors.melissa.description":"Antiga OCM - Adobe\nStanford DCI Fellow\nMembro da Direcção - CommonSpirit Health","team.teamSection.advisors.melissa.title":"Consultor Executivo de Marketing","team.teamSection.advisors.hugo.name":"Hugo Estrada","team.teamSection.advisors.hugo.description":"CEO & Managing Partner na iwé Consultores\nChairman of Nueva EPS (Seguro Saúde)","team.teamSection.advisors.hugo.title":"Assessor Executivo de divulgação on Colômbia","team.teamSection.advisors.pedro.name":"Pedro Siena","team.teamSection.advisors.pedro.description":"Fundador e Chefe Executivo - Siena Company\nMentor - Stanford Lean Launchpad\nSão Carlos, Brazil","team.teamSection.advisors.pedro.title":"Conselheiro de divulgação no Brasil","team.teamSection.advisors.tsutomu.name":"Tsutomu Ito","team.teamSection.advisors.tsutomu.description":"Fundador - Tannan Rádio FM\nLead Architect, Bullet Train\nFukui, Japan","team.teamSection.advisors.tsutomu.title":"Conselheiro Visionário","team.teamSection.advisors.taisuke.name":"Taisuke Fukuno","team.teamSection.advisors.taisuke.description":"Fundador - Open Data Japan\nPresidente - jig.jp\nFukui, Japan","team.teamSection.advisors.taisuke.title":"Conselheiro Executivo de Tecnologia","team.teamSection.advisors.victor.name":"Victor Wang","team.teamSection.advisors.victor.description":"Fundador e Presidente em China Silicon Valley\nCEO at SinoSV LLC","team.teamSection.advisors.victor.title":"Consultor Executivo","team.teamSection.advisors.alfonso.name":"Alfonso Assaf","team.teamSection.advisors.alfonso.description":"Ex-consultor sénior, Deloitte\nB.A. Economics, Universidad del CEMA","team.teamSection.advisors.alfonso.title":"Gestor de Divulgação da Comunidade Argentina","team.teamSection.advisors.richardswart.name":"Richard Swartzbaugh","team.teamSection.advisors.richardswart.description":"Curaesoft, Managing Director & Chief Risk Officer\nJuris Doctorate, University of Iowa","team.teamSection.advisors.richardswart.title":"Healthcare / Software Executive","team.valuesSection.less":"Menos","team.valuesSection.more":"Mais","team.valuesSection.vision.header":"A visão da Virufy","team.valuesSection.vision.pg1":"Aspiramos a ser a principal organização sem fins lucrativos para a identificação de doenças com base em tecnologia.","team.valuesSection.vision.pg2":"As nossas inovações visam oferecer uma detecção superior para doentes, clínicos e governos.","team.valuesSection.vision.pg3":"Seremos a força para transformar os cuidados de saúde globais e para inspirar o apoio e o investimento nesta missão.","team.valuesSection.values.transform.header":"Transformar","team.valuesSection.values.transform.pg":"Os sistemas de saúde são caros e lentos a mudar, mas com a tecnologia podemos impulsionar a transformação a nível global.","team.valuesSection.values.world.header":"Mundo","team.valuesSection.values.world.pg":"Existimos para todos, independentemente dos nossos antecedentes. Reconhecemos que a necessidade mais premente está nos mercados emergentes, mas que os cuidados de saúde podem ser inacessíveis mesmo nos mercados desenvolvidos.","team.valuesSection.values.free.header":"Grátis","team.valuesSection.values.free.pg":"Para muitos, os cuidados de saúde são inacessíveis. Não vemos qualquer razão para que as pessoas tenham de pagar por prevenção e detecção dispendiosas quando estas podem ser gratuitas com a ajuda da tecnologia.","team.valuesSection.values.health.header":"Saúde","team.valuesSection.values.health.pg":"A saúde das pessoas é a coisa mais preciosa do mundo. Da saúde vem a felicidade, e dela vem o sucesso social e económico.","team.valuesSection.values.oneTap.header":"Uma torneira","team.valuesSection.values.oneTap.pg":"O nosso único foco é a utilização da tecnologia para melhorar a saúde das pessoas - é tudo o que fazemos. As nossas aplicações são sofisticadas mas intuitivas, proporcionando uma detecção rápida para prevenir a propagação do vírus e salvar vidas.","team.valuesSection.values.mobile.header":"Móvel","team.valuesSection.values.mobile.pg":"Os dispositivos móveis tornaram-se omnipresentes nos mercados em desenvolvimento e podem ser utilizados para a prestação de cuidados de saúde.","team.valuesSection.values.header":"Our values","team.valuesSection.section4.header":"Os nossos valores","team.valuesSection.section4.pg1":"Virufy é um projecto do Laboratório de Inovação de Resposta de Stanford COVID-19 e é também apresentado no One Young World"},"routed":true,"originalPath":"/oyw/","redirect":true,"defaultLanguage":"en"}}},"staticQueryHashes":["1390410445"]}